DEXLEVO INC.
Dexlevo Inc., founded in 2013 and based in Seoul, South Korea, is a pioneering company specializing in the development of advanced medical aesthetic products using biodegradable polymer technology. The company's flagship product, GOURI, is the world's first fully solubilized liquid polycaprolactone (PCL) injectable. Unlike traditional fillers, GOURI is a liquid before injection and transforms into a 3D matrix within the skin, promoting collagen regeneration and providing a more natural and even distribution. Dexlevo's innovative approach has garnered significant attention in the global market. The company has secured CE certification for its liquid polymer fillers, enabling it to expand its reach across Europe, the Middle East, and Latin America. Dexlevo has also formed strategic partnerships with global distributors, resulting in multi-million-dollar contracts and further solidifying its presence in the aesthetic medicine industry. The company aims to continue its growth by obtaining regulatory approvals in additional markets, including South Korea and the United States, and plans to go public on the KOSDAQ market. Dexlevo's commitment to research and development, coupled with its unique polymer technology, positions it as a leader in the field of medical aesthetics.
DEXLEVO INC. Introduction
Founded in 2013 in South Korea, DEXLEVO develops beauty products based on biodegradable polymer technology. The company developed the world’s first liquid polymer fillers patented technology, CESABP (Collagen Enabled Solubilized Active and Biodegradable Polymer), a fully solubilized biocompatible and biodegradable PCL (Polycaprolactone), which distributes efficiently into the skin. The technology effectively creates collagen synthesis on the entire skin. This results in, improvement of skin thickness, density, and elasticity without lumps or nodules. It is a complete innovation for fundamental anti-aging.
DEXLEVO has used this technology to develop the next-generation collagen stimulator, Gouri.